David Sinclair's XPRIZE Rejuvenation Plan Has a Proof Problem
The real story is not another anti-aging pill claim. It is whether whole-body rejuvenation can survive XPRIZE's measurement machine.
Understand how researchers study aging, what experiments can establish, and why healthier human lives require stronger evidence than promising mechanisms or impressive biological measurements.
Jump to the latest articles ↓Three places to begin. Selected for the questions they help you answer.
Longevity science is real. The hard part is knowing which claims have moved from mechanism to human proof.
· 6 min readNIH's SenNet atlas does not prove an anti-aging therapy. It gives longevity science a harder measurement layer.
· 6 min readNinety-two days draws attention. Keeping three mouse experiments and two human studies separate reveals what the result can actually tell us.
· 4 min readThe real story is not another anti-aging pill claim. It is whether whole-body rejuvenation can survive XPRIZE's measurement machine.
The first human dosing of ER-100 does not prove age reversal. It starts the evidence clock for one of longevity's boldest ideas.
Two major Alzheimer's trials showed semaglutide did not slow clinical decline. The result is a hard lesson in what evidence can and cannot prove.
Longevity will not become serious medicine until it proves what its numbers actually mean.
Rapamycin has real longevity science behind it. That does not make it a proven anti-aging drug for healthy humans.
ER-100 is a narrow eye-disease trial, but it may be the first real test of whether cellular rejuvenation can survive clinical evidence.
Exponential tools are colliding with non-exponential biology.
Longevity does not automatically create planetary collapse. The real burden depends on whether extra years are healthy or dependent, low-carbon or resource-heavy, shared or stratified.
Epigenetic clocks can be useful research tools and decent trend signals. They become dangerous when people treat them like destiny.
A consequential story, the evidence behind it and the connection that makes it matter. A short read, with room to think.
Occasional editions. Free to subscribe. Unsubscribe anytime.